Traws Pharma, Inc. revenue for the last year amounted to 226.00 k USD, the most of which — 226.00 k USD — came from its highest performing source at the moment, Oncology Therapeutics, the year earlier bringing 226.00 k USD. The greatest contribution to the revenue figure was made by United States — last year it brought Traws Pharma, Inc. 226.00 k USD, and the year before that — 226.00 k USD.